Delivery Order SPE2DB22D1041-SPE2DB25FUBU4
- Not listed
- The Defense Logistics Agency awarded a $11,026.06 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 17, 2025. The order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $2,208.90. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,604.85 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30. This competitively awarded, firm fixed-price contract carries an ultimate completion date of May 9, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,825.48 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) on September 11, 2025, with a completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The award is being fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) under a firm fixed-price contract valued at $1,839.98. This non-set-aside delivery order, issued on August 29, 2025, with completion targeted for September 2, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,688.37 to AmerisourceBergen Drug Corp for 30-count tablets of Modafinil 100 mg, with completion scheduled for August 14, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,276.86 to AmerisourceBergen Drug Corp for Modafinil 100 mg tablets (30-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- AmerisourceBergen Drug Corp was awarded a delivery order for Modafinil 100 mg tablets (quantity 30s) by the Defense Logistics Agency on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract is valued at $3,939.53 and is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This...
- The Defense Logistics Agency awarded a $3,583.68 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units. This firm fixed price contract, with an ultimate completion date of August 25, 2025, represents a non-set-aside competitive award supporting the federal government's pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30s, with a contract ceiling value of $1,423.58. This competitively awarded, firm fixed-price delivery order is classified as a child contract with an ultimate completion date of August 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBU4Delivery Order
The Defense Logistics Agency awarded a $1,476.93 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Modafinil 100 mg tablets (30-count) with completion scheduled for September 8, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA Troop Support Medical (SPE2DX), a $999.999 billion indefinite delivery vehicle extending through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates substantial capability in fulfilling Defense and Veterans Affairs pharmaceutical procurement requirements across multiple therapeutic domains, positioning the company as a critical vendor for federal medical supply needs within the military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/5/25 |